Key Takeaway
Average weight loss on liraglutide 1.2mg. Covers realistic expectations, comparison to the full 3.0mg dose, and why results at 1.2mg are modest but encouraging.
Average weight loss during the one-week liraglutide 1.2mg phase is 1 to 2 pounds. Over longer treatment periods at 1.2mg (as used for diabetes with Victoza), studies show average weight loss of approximately 3 to 4 percent of body weight. This is less than half the result seen at the full 3.0mg weight management dose, which produces about 8 percent average loss. The 1.2mg dose is a stepping stone, not a destination, for patients pursuing weight loss.
Weight Loss During the 1.2mg Titration Week
For patients passing through 1.2mg during the standard titration, here is what the scale typically shows:
| Timeframe | Typical Weight Change |
|---|---|
| Week 1 (0.6mg) | 0-2 lbs lost |
| Week 2 (1.2mg) | 1-2 lbs lost |
| Cumulative after 2 weeks | 1-4 lbs total |
These numbers are modest by design. You're still building toward the therapeutic dose. The weight loss at 1.2mg comes primarily from reduced food intake (a function of growing appetite suppression) and mild water loss.
Long-Term Data at 1.2mg (Victoza Studies)
Because 1.2mg is the standard diabetes dose, we have extensive long-term data from the LEAD (Liraglutide Effect and Action in Diabetes) trial program:
View data table
| Category | Mean Body Weight Loss (%) | Detail |
|---|---|---|
| Tirzepatide | 22 | ~22% body weight at 72 wks |
| Semaglutide | 15 | ~15% body weight at 68 wks |
| Liraglutide | 8 | ~8% body weight at 56 wks |
| Retatrutide | 24 | ~24% in Phase 2 trial |
- Average weight loss: 2 to 3 kg (4.4 to 6.6 lbs) over 26 weeks in patients with type 2 diabetes
- Percentage of body weight: Approximately 2.5 to 3.5 percent
- Compared to placebo: 1 to 2 kg (2.2 to 4.4 lbs) more than placebo
- Compared to liraglutide 1.8mg: About 0.5 to 1 kg less than the 1.8mg dose
These results underscore that 1.2mg has real weight loss activity, but it's less than half of what the 3.0mg dose delivers. For patients whose primary goal is weight management, moving through the titration to higher doses is important. liraglutide 1.8mg weight loss average
Why 1.2mg Produces Less Weight Loss
The dose-response relationship for liraglutide and weight loss isn't linear. Here is how the doses compare:
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →| Dose | Approximate Weight Loss (Long-Term) | Appetite Suppression Level |
|---|---|---|
| 0.6mg | ~1% (titration only) | Minimal |
| 1.2mg | ~3-4% | Moderate |
| 1.8mg | ~4-5% | Moderate-strong |
| 3.0mg | ~8% | Strong |
At 1.2mg, the GLP-1 receptor activation is sufficient for blood sugar management but below the level needed for strong weight loss. The appetite centers in the brain require higher doses for the full satiety-signaling effect.
Making the Most of the 1.2mg Phase
Even though weight loss is modest at 1.2mg, you can use this phase productively:
- Establish protein habits: Start aiming for 60 to 80 grams of protein daily. At higher doses, reduced appetite will make it harder to eat enough, so building protein-rich eating patterns now pays off later.
- Begin or increase exercise: The mild appetite reduction at 1.2mg rarely interferes with exercise performance. Establishing a workout routine now means it's already a habit when the medication's full weight loss effect kicks in.
- Track your food: Use a simple log or app. Understanding your baseline eating patterns helps you make informed adjustments at higher doses.
- Reduce liquid calories: Sodas, juices, and specialty coffee drinks can account for hundreds of hidden calories. Eliminating these now amplifies the medication's effect at every dose level.
Frequently Asked Questions
- I haven't lost any weight at 1.2mg. Should I be worried?
- No. Zero weight loss at 1.2mg after one week is completely normal and says nothing about your potential response at 3.0mg. The dose is sub-therapeutic for weight management. Continue the titration.
- How does liraglutide 1.2mg weight loss compare to semaglutide at its starting doses?
- Semaglutide 0.25mg (the starting dose for Wegovy) produces similar minimal weight loss during the titration phase. Both medications reserve their major weight loss effect for the full therapeutic dose. At their respective maximum doses, semaglutide 2.4mg outperforms liraglutide 3.0mg. liraglutide vs semaglutide
- If 1.2mg is working for my diabetes, do I need the higher weight loss doses?
- That depends on your goals. If your A1C is controlled and your weight is stable at 1.2mg, you may not need to go higher. If weight loss is also a priority, titrating toward 3.0mg will provide significantly more weight management benefit. Discuss your priorities with your prescriber.
- Can lifestyle changes make up for the lower dose?
- Lifestyle changes always enhance results regardless of dose. But at 1.2mg, the medication provides only modest pharmacological support. The combination of aggressive lifestyle changes plus the 3.0mg dose produces the best outcomes. Think of lifestyle and medication as complementary, not interchangeable.
Talk to a licensed provider
Start your free assessment. A licensed provider reviews every request before anything is prescribed, and not everyone qualifies.
Start the assessment →